Argo Biopharma specializes in siRNA drug discovery and development. Our industry-leading siRNA platform technology, RADS (RNA molecules with superior Activity, Durability, and Safety), is the cornerstone of our innovative approach. Based on this platform, drugs can achieve the expected one injection per year in clinical practice in some indications.